- Tandem Diabetes Care Announces Second Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance
- Tandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical
- Tandem Diabetes Care to Announce Second Quarter 2022 Financial Results on August 3, 2022
- Tandem Diabetes Care Welcomes Two New Members to Board of Directors
- Control-IQ Technology Continues to Demonstrate Positive and Sustained Real-World Benefits Across Diverse Cohorts of People with Diabetes
- Tandem Diabetes Care Announces Upcoming Virtual Conference Presentation
As of last trade
Tandem Diabetes Care Inc (TNDM:NMQ) traded at 55.60, 6.76% above its 52-week low of 52.08, set on Jul 13, 2022.
52.08Jul 13 2022155.86Dec 28 2021
Markit short selling activity
|Market cap||3.56bn USD|
|EPS (TTM)||-0.2091 |
Data delayed at least 15 minutes, as of Aug 15 2022 17:13 BST.